World's Best Scientists 2026 revealed!

D-Index & Metrics

Neuroscience

D-Index
38
Citations
5798
World Ranking
8560
National Ranking
3642

Overview

Mika Naganawa is affiliated with Yale University in the United States and has contributed extensively to the fields of Medicine and Neuroscience. Their research primarily focuses on Radiology, Nuclear Medicine and Imaging, Cognitive Neuroscience, Cellular and Molecular Neuroscience, Physiology, and Psychiatry and Mental health.

The main topics addressed in Naganawa's work include Functional Brain Connectivity Studies, Neuroscience and Neuropharmacology Research, Alzheimer's disease research and treatments, Medical Imaging Techniques and Applications, Advanced MRI Techniques and Applications, Epilepsy research and treatment, and Neurological disorders and treatments.

Frequent publication venues for Naganawa's research include:

  • Alzheimer s & Dementia
  • Journal of Nuclear Medicine
  • Biological Psychiatry
  • Molecular Psychiatry
  • European Journal of Nuclear Medicine and Molecular Imaging

Among recent research papers authored or co-authored by Naganawa are:

  • In vivo measurement of widespread synaptic loss in Alzheimer's disease with SV2A PET, 2020, Alzheimer s & Dementia
  • Synaptic Changes in Parkinson Disease Assessed with in vivo Imaging, 2020, Annals of Neurology
  • Synaptic density and cognitive performance in Alzheimer's disease: A PET imaging study with [11C]UCB-J, 2022, Alzheimer s & Dementia
  • First-in-Human Evaluation of 18F-SynVesT-1, a Radioligand for PET Imaging of Synaptic Vesicle Glycoprotein 2A, 2020, Journal of Nuclear Medicine
  • Association of Aβ deposition and regional synaptic density in early Alzheimer's disease: a PET imaging study with [11C]UCB-J, 2021, Alzheimer s Research & Therapy

Frequent co-authors who have collaborated with Naganawa include:

  • Richard E. Carson
  • Nabeel Nabulsi
  • Takuya Toyonaga
  • Yiyun Huang
  • David Matuskey

Best Publications

  • Lower synaptic density is associated with depression severity and network alterations.

    Sophie E. Holmes;Dustin Scheinost;Sjoerd J. Finnema;Mika Naganawa

  • Assessing Synaptic Density in Alzheimer Disease With Synaptic Vesicle Glycoprotein 2A Positron Emission Tomographic Imaging.

    Ming-Kai Chen;Adam P. Mecca;Mika Naganawa;Sjoerd J. Finnema

  • In vivo measurement of widespread synaptic loss in Alzheimer's disease with SV2A PET

    Adam P Mecca;Ming-Kai Chen;Ryan S O'Dell;Mika Naganawa

  • Synaptic density and cognitive performance in Alzheimer's disease: A PET imaging study with [11C]UCB‐J

    Unknown

  • Synaptic Changes in Parkinson Disease Assessed with in vivo Imaging.

    David Matuskey;Sule Tinaz;Kyle C. Wilcox;Mika Naganawa

  • High occupancy of sigma-1 receptors in the human brain after single oral administration of fluvoxamine: a positron emission tomography study using [11C]SA4503.

    Masatomo Ishikawa;Kiichi Ishiwata;Kenji Ishii;Yuichi Kimura

  • Extraction of a plasma time-activity curve from dynamic brain PET images based on independent component analysis

    M. Naganawa;Y. Kimura;K. Ishii;K. Oda

  • Adenosine A2A Receptors Measured with [11C]TMSX PET in the Striata of Parkinson's Disease Patients

    Masahiro Mishina;Kiichi Ishiwata;Mika Naganawa;Yuichi Kimura

  • First-in-Human Evaluation of 18F-SynVesT-1, a Radioligand for PET Imaging of Synaptic Vesicle Glycoprotein 2A.

    Mika Naganawa;Songye Li;Nabeel B Nabulsi;Shannan Henry

  • Assessment of a white matter reference region for 11C-UCB-J PET quantification.

    Samantha Rossano;Takuya Toyonaga;Sjoerd J Finnema;Mika Naganawa

  • Imaging of Synaptic Density in Neurodegenerative Disorders.

    Unknown

  • Association of Aβ deposition and regional synaptic density in early Alzheimer's disease: a PET imaging study with [11C]UCB-J.

    Ryan S. O’Dell;Adam P. Mecca;Ming-Kai Chen;Mika Naganawa

  • Clinical doses of atomoxetine significantly occupy both norepinephrine and serotonin transports: Implications on treatment of depression and ADHD

    Yu-Shin Ding;Yu-Shin Ding;Mika Naganawa;Jean-Dominique Gallezot;Nabeel Nabulsi

  • In vivo evidence of lower synaptic vesicle density in schizophrenia.

    Rajiv Radhakrishnan;Patrick D Skosnik;Mohini Ranganathan;Mika Naganawa

  • Evaluation of distribution of adenosine A2A receptors in normal human brain measured with [11C]TMSX PET.

    Masahiro Mishina;Kiichi Ishiwata;Yuichi Kimura;Mika Naganawa

  • First-in-Human Assessment of 11C-LSN3172176, an M1 Muscarinic Acetylcholine Receptor PET Radiotracer.

    Mika Naganawa;Nabeel B Nabulsi;Shannan Henry;David Matuskey

  • Imaging the effect of ketamine on synaptic density (SV2A) in the living brain

    Unknown

  • Association of In Vivo κ-Opioid Receptor Availability and the Transdiagnostic Dimensional Expression of Trauma-Related Psychopathology

    Robert H. Pietrzak;Robert H. Pietrzak;Mika Naganawa;Yiyun Huang;Stefani Corsi-Travali

  • Comparison of [11C]UCB-J and [18F]FDG PET in Alzheimer’s disease: A tracer kinetic modeling study:

    Ming-Kai Chen;Adam P Mecca;Mika Naganawa;Jean-Dominique Gallezot

  • In Vivo Synaptic Density Imaging with 11C-UCB-J Detects Treatment Effects of Saracatinib in a Mouse Model of Alzheimer Disease

    Takuya Toyonaga;Levi M. Smith;Sjoerd J. Finnema;Jean-Dominique Gallezot

  • Evaluation of the agonist PET radioligand [¹¹C]GR103545 to image kappa opioid receptor in humans: kinetic model selection, test-retest reproducibility and receptor occupancy by the antagonist PF-04455242

    Mika Naganawa;Leslie K. Jacobsen;Ming-Qiang Zheng;Shu-Fei Lin

  • Mapping of human cerebral sigma1 receptors using positron emission tomography and [11C]SA4503.

    Muneyuki Sakata;Yuichi Kimura;Mika Naganawa;Keiichi Oda

  • Reduced synaptic vesicle protein 2A binding in temporal lobe epilepsy: A [11 C]UCB-J positron emission tomography study.

    Sjoerd J. Finnema;Takuya Toyonaga;Kamil Detyniecki;Ming‐Kai Chen

  • A single-center, open-label positron emission tomography study to evaluate brivaracetam and levetiracetam synaptic vesicle glycoprotein 2A binding in healthy volunteers.

    Sjoerd J. Finnema;Samantha Rossano;Mika Naganawa;Shannan Henry

Frequent Co-Authors

Nabeel Nabulsi
Nabeel Nabulsi Yale University
Amy F.T. Arnsten
Amy F.T. Arnsten Yale University
Kenji Ishii
Kenji Ishii Nippon Medical School
Keiichi Oda
Keiichi Oda Hokkaido University of Science
Robert H. Pietrzak
Robert H. Pietrzak Yale University
Iwao Kanno
Iwao Kanno National Institutes for Quantum and Radiological Science and Technology
Hiroshi Ito
Hiroshi Ito Fukushima Medical University
Ronald S. Duman
Ronald S. Duman Yale University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you're interested in neuroscience but want to explore related fields or expand your qualifications, there are multiple online study options to consider. Pursuing online certification programs can boost your skill set quickly and provide flexible, specialized training in areas like data analysis, mental health, or research methods.

For those seeking a fast and accessible route to a bachelor's qualification, several easy bachelor degrees online can open doors to healthcare, education, or management careers without an extensive background in science.

Students passionate about helping others may look into online graduate programs such as the msw, ideal for those aiming to work in social work, counseling, or community support. Additionally, an online path to become a behavior analyst is available through the bcba degree online, preparing graduates for in-demand roles supporting individuals with behavioral or developmental challenges.

With these diverse online pathways, students interested in neuroscience can gain valuable credentials and pursue fulfilling careers in related fields.

Best Scientists Citing Mika Naganawa

Trending Scientists